| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |